The oncogenic potential of CDKN2B‐AS1 across different cancers, including its regulatory effects on miR‐378b in lung cancer, further validates the multifaceted roles of these lncRNAs in oncogenesis [56, 57]. This evidence concerns the gene CDKN2B and cancer.